These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8665020)

  • 1. Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature.
    Hendrikx M; Van Dorpe J; Flameng W; Daenen W
    J Heart Valve Dis; 1996 Mar; 5(2):235-7. PubMed ID: 8665020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature.
    Hauck AJ; Edwards WD; Danielson GK; Mullany CJ; Bresnahan DR
    Arch Pathol Lab Med; 1990 Jan; 114(1):62-4. PubMed ID: 2403780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac surgery for ergotamine-induced multivalvular heart disease.
    Lazopoulos G; Papaioannou G; Kantartzis M
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):435-7. PubMed ID: 23475795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical case of the month. Triple valvular dysfunction associated with long-term ergotamine therapy].
    Goujon-Dubois J; el Allaf D
    Rev Med Liege; 2003 Feb; 58(2):70-2. PubMed ID: 12693305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From headache to heartache: ergotamine-induced aortic and mitral valvulopathy.
    Patel SM; Ohori NP; Badhwar V; Cavalcante JL
    J Am Coll Cardiol; 2013 Dec; 62(22):2144. PubMed ID: 24067402
    [No Abstract]   [Full Text] [Related]  

  • 6. Spasm of arm arteries due to ergotamine tartrate. A case report.
    Palombo D; Mirelli M; Peinetti F; Porta C; Brustia P; Udini M
    Int Angiol; 1991; 10(1):51-3. PubMed ID: 2071975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitral, aortic and tricuspid valvular heart disease associated with ergotamine therapy for migraine.
    Wilke A; Hesse H; Hufnagel G; Maisch B
    Eur Heart J; 1997 Apr; 18(4):701. PubMed ID: 9129909
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for migraine.
    Med Lett Drugs Ther; 1976 Jun; 18(13):55-6. PubMed ID: 934019
    [No Abstract]   [Full Text] [Related]  

  • 9. [Valvular heart disease associated with ergotamine].
    Martínez Quintana E; Llorens León R; Redondo Martínez E; Nieto Lago V; Jiménez Cabrera F; Gross Kastanovitz E
    Rev Esp Cardiol; 2005 Jan; 58(1):97-9. PubMed ID: 15680136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitral regurgitation caused by chronic ergotamine use.
    Flaherty KR; Bates JR
    Am Heart J; 1996 Mar; 131(3):603-6. PubMed ID: 8604645
    [No Abstract]   [Full Text] [Related]  

  • 11. [Peripheral ischaemia after chronic ergot poisoning].
    Rodríguez de Cossío A; Rodríguez Sánchez R; Alonso Moreno FJ
    Neurologia; 2010 Oct; 25(8):518-9. PubMed ID: 20965006
    [No Abstract]   [Full Text] [Related]  

  • 12. Quadricuspid semilunar valves: report of two cases.
    Hwang DM; Feindel CM; Butany JW
    Can J Cardiol; 2003 Jul; 19(8):938-42. PubMed ID: 12876615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Images in clinical medicine. Four artificial heart valves.
    Bijl M; van den Brink RB
    N Engl J Med; 2005 Aug; 353(7):712. PubMed ID: 16107624
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic rheumatic heart disease in India: a reappraisal of pathologic changes.
    Chopra P; Bhatia ML
    J Heart Valve Dis; 1992 Sep; 1(1):92-101. PubMed ID: 1341228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valvular heart disease: the influence of changing etiology on nosology.
    Boudoulas H; Vavuranakis M; Wooley CF
    J Heart Valve Dis; 1994 Sep; 3(5):516-26. PubMed ID: 8000586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].
    Creutzig A
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1736. PubMed ID: 1425287
    [No Abstract]   [Full Text] [Related]  

  • 17. Histologic changes in three explanted native cardiac valves following use of fenfluramines.
    Steffee CH; Singh HK; Chitwood WR
    Cardiovasc Pathol; 1999; 8(5):245-53. PubMed ID: 10533956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valvular heart disease associated with fenfluramine detected 7 years after discontinuation of treatment.
    Greffe G; Chalabreysse L; Mouly-Bertin C; Lantelme P; Thivolet F; Aulagner G; Obadia JF
    Ann Thorac Surg; 2007 Apr; 83(4):1541-3. PubMed ID: 17383382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitral bioprosthesis hypertrophic scaring and native aortic valve fibrosis during benfluorex therapy.
    Ayme-Dietrich E; Lawson R; Gasser B; Dallemand R; Bischoff N; Monassier L
    Fundam Clin Pharmacol; 2012 Apr; 26(2):215-8. PubMed ID: 22320434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-associated valvular heart disease in Hodgkin's disease is associated with characteristic thickening and fibrosis of the aortic-mitral curtain.
    Brand MD; Abadi CA; Aurigemma GP; Dauerman HL; Meyer TE
    J Heart Valve Dis; 2001 Sep; 10(5):681-5. PubMed ID: 11603609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.